Presence of antiphospholipid antibodies in COVID-19: a case series study | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a Reply. Please see:

Response to: ‘Presence of anti-phospholipid antibodies in COVID-19: a case series study’ by Amezcua-Guerra et al - May 01, 2021

Correspondence

Presence of antiphospholipid antibodies in COVID-19: a case series study

Online download statistics by month:

Online download statistics by month: August 2020 to May 2023

	Abstract	Full	Pdf
Aug 2020	1578	1567	209
Sep 2020	399	347	126
Oct 2020	297	315	79
Nov 2020	413	415	90
Dec 2020	282	281	69
Jan 2021	262	258	55
Feb 2021	244	243	74
Mar 2021	169	169	54
Apr 2021	412	395	99
May 2021	263	231	111
Jun 2021	147	125	69
Jul 2021	179	165	39
Aug 2021	135	126	45
Sep 2021	119	99	63
Oct 2021	147	118	57
Nov 2021	116	98	71
Dec 2021	106	81	41
Jan 2022	140	120	43
Feb 2022	144	127	57
Mar 2022	109	101	32
Apr 2022	123	110	31
May 2022	133	128	28
Jun 2022	109	105	27
Jul 2022	84	72	22
Aug 2022	87	78	24
Sep 2022	68	60	21
Oct 2022	58	50	15
Nov 2022	46	39	23
Dec 2022	48	45	30
Jan 2023	56	53	14
Feb 2023	53	51	15
Mar 2023	59	51	13
Apr 2023	100	3	9
May 2023	69	5	3
Total	6754	6231	1758